Search

Searching with a thematic focus on HIV and AIDS, Access to treatment, HIV and AIDS treatment and care, ARVs, TRIPS and patents

Showing 1-4 of 4 results

• Document

  Towards universal access: assessment by the Joint United Nations Programme on HIV/AIDS on scaling up HIV prevention, treatment, care and support

  Joint United Nations Programme on HIV/AIDS, 2006

  This publication, produced by UNAIDS, provides an update on the status of scaling up HIV prevention, treatment, care and support. It is based on numerous consultations and submissions from country members. The document identifies a number of key challenges that stand in the way of universal access.
• Document

  Generic competition, price and access to medicines: the case of antiretrovirals in Uganda

  Oxfam, 2002

  This paper outlines the findings of Oxfam research into the accessibility of ARV therapy in Uganda since 2000. During that year two important events improved access to these medicines. First, five drug companies agreed to reduce the price of some ARVs under a UNAIDS scheme.
• Document

  The FTAA, access to HIV/AIDS treatment, and human rights

  Human Rights Watch, 2002

  This briefing paper begins by giving an outline of the WTO’s Trade Related Aspects of Intellectual Property Agreement (TRIPS) and of the Doha declaration by WTO members, which states that countries can bypass patents in medical emergencies.The paper argues that countries in the Free Trade Area of the Americas (FTAA) should resist pressure from the Office of the United States Trade Representativ
• Document

  Drug companies vs. Brazil: the threat to public health

  Oxfam, 2001

  The access of impoverished Brazilians to essential medicines, including those required for treatment of HIV/AIDS, is under threat.